|
Market Cap (24-Jun) $19,510,578 (1,113th) |
Close (30-Jun) $0.049 |
Volume (30-Jun) 1,094,468 |
Shortsold (12-Jul) 1 (0.00%) (672nd) |
|
52w High $0.000 |
52w Low $0.000 |
P/E 20.45 |
EPS -0.02 |
A news article has been posted about Pharmaxis Ltd on the AFR. The article was published around , on 15 November 2021 at 1:08pm.
Pharmaxis is tapping investors to raise $9.2 million, with the capital set to support the next phase of clinical trials for its cancer and scar treatment candidates.
Read ArticlePXS was $0.115 at the close of trade on 12 November 2021
| Recent Articles about ASX:PXS | |
|---|---|
| 21-Dec | Arovella Therapeutics Limited ACN 090 987 250 Notice of Annual ...
company-announcements.afr.com |
| 12-Nov | https://www.afr.com/sitemaps/afr-articles-20211115.xml
afr.com |
| 12-Nov | https://www.afr.com/sitemaps/afr-articles-20140708.xml
afr.com |
| 14-Nov | FITZROY RIVER CORPORATION LTD
company-announcements.afr.com |
| 3-Oct | Chairman's Address to AGM
company-announcements.afr.com |
| 7-Sep | BioTech Capital Limited ABN 45 091 979 172
company-announcements.afr.com |
| 7-Sep | CEO PRESENTATION
company-announcements.afr.com |
| 5-Sep | Annual Report
company-announcements.afr.com |
| 22-Aug | Chairman's Address to Shareholders
company-announcements.afr.com |
| 29-Jun | Annual Report 2023 | Actinogen Medical
company-announcements.afr.com |
| Tracked |
Find all articles about Pharmaxis Ltd, including others on the AFR, on the media page.
You must be logged in to post a reply.
Pharmaxis Ltd 